SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark Marcellus who wrote (3428)12/7/2000 4:59:54 PM
From: rli123  Read Replies (1) of 5582
 
Mark -- your observations are interesting, but your conclusions, IMHO, miss the "mark." First, the stocking of the drug store shelves is not part of what GUMM does -- they are not like Frito-Lay --- they don't deliver product and stock the shelves. Ordering product and stocking the shelf is what the drugstore company does. So criticism about lack of product on the shelf should be directed to the drug store company, not GUMM. Similiarly, criticism of overstocking of allergy product should also be directed to the store, not GUMM.

I think they've done an outstanding job in getting their product onto store shelves. Now let's see if the big advertising budget will translate into sales. If it does, we'll all be pleased (except the shorts).
rli
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News